Dymeclin is a Golgi-associated protein whose deficiency causes Dyggve-Melchior-Clausen syndrome (DMC, MIM #223800), a rare recessively inherited spondyloepimetaphyseal dysplasia consistently associated with postnatal microcephaly and intellectual disability. While the skeletal phenotype of DMC patients has been extensively described, very little is known about their cerebral anomalies, which result in brain growth defects and cognitive dysfunction. We used Dymeclin-deficient mice to determine the cause of microcephaly and to identify defective mechanisms at the cellular level. Brain weight and volume were reduced in all mutant mice from postnatal day 5 onward. Mutant mice displayed a narrowing of the frontal cortex, although cortical layers were normally organized. Interestingly, the corpus callosum was markedly thinner, a characteristic we also identified in DMC patients. Consistent with this, the myelin sheath was thinner, less compact and not properly rolled, while the number of mature oligodendrocytes and their ability to produce myelin basic protein were significantly decreased. Finally, cortical neurons from mutant mice and primary fibroblasts from DMC patients displayed substantially delayed endoplasmic † N.D. and A.F. equally contributed to this work. § S.P. and P.G. equally contributed to this work
Introduction
Dyggve-Melchior-Clausen syndrome (DMC, MIM #223800) is a severe autosomal-recessive spondyloepimetaphyseal dysplasia associated with microcephaly and intellectual disability, caused by loss-of-function mutations in the DYM gene encoding DYMECLIN, a Golgi protein thought to be involved in intracellular trafficking (1) (2) (3) . The skeletal manifestations of the disease include short-trunk dwarfism with specific radiological features, severe proximal limb shortening and facial dysmorphism (4) . Microcephaly is also consistently observed in DMC along with mild-to-severe intellectual disability, frequently including poor or absent language acquisition (5) (6) (7) (8) (9) . Interestingly, both skeletal growth defects and microcephaly develop during childhood and are therefore rarely diagnosed at birth. This suggests that the physiological mechanisms affected in DMC involve postnatal processes. Interestingly, Smith-McCort Dysplasia 1 (SMC1, MIM #607326), an allelic spondyloepimetaphyseal dysplasia with skeletal features identical to DMC but with normal intelligence and no microcephaly, also results from mutations in DYM (10,11), whereas Smith-McCort Dysplasia 2 (SMC2, MIM #615222) is caused by homozygous mutations in RAB33B, another Golgi protein involved in trafficking (12, 13) . Importantly, DYM mutations causing SMC1 consist of missense substitutions that do not lead to protein degradation but may instead result in some residual activity of the protein. In contrast, DMC is associated with truncating mutations predicted to induce a loss of DYM function (1) . This suggests that the cerebral phenotype is associated with a complete deficiency of DYMECLIN and that its role in the brain could be different from that in the bone. Biochemical and live-imaging studies indicate that DYMECLIN is associated with Golgi membranes (1, 3) and is perpetually shuttled between the Golgi and cytosolic pools in a highly dynamic manner (1) . Consistent with this, several Golgi vesicle proteins have been identified as potential DYMECLIN interactors (3, 14) . These findings argue for a role of DYM in Golgi homeostasis and/or Golgi-associated vesicular trafficking. Mice deficient in Dymeclin develop progressive skeletal abnormalities reminiscent of human DMC/ SMC phenotypes (3) . However, the brain phenotype of these mutant mice has never been investigated.
In this study, we analyzed the cerebral phenotype of Dymdeficient mice as well as two DMC patients to understand the role of Dymeclin in brain development. We found that Dymdeficient mice developed microcephaly postnatally, with a narrowing of the frontal cortex, a thinner corpus callosum associated with hypomyelinated axons and a reduced number of oligodendrocytes. This was accompanied at the cellular level by an enlarged Golgi apparatus in both mature oligodendrocytes and cortical neurons. While oligodendrocytes showed a reduced capacity to produce the myelin basic protein (MBP), cortical neurons showed a strong impairment of endoplasmic reticulum (ER)-to-Golgi transport, a function also altered in fibroblasts from DMC patients. Furthermore, we found that in addition to postnatal microcephaly, the brains of the two patients with DMC displayed a thinning of the corpus callosum, reinforcing the link between altered Dymeclin function and brain development.
Results

Dym
−/− mice develop postnatal microcephaly
In humans, most microcephalies are congenital, but some occur after birth and become more pronounced during childhood (15) . To determine whether the Dym mutation causes microcephaly in mice, we used homozygous Dym-mutant mice lacking normal Dym transcript expression and previously shown to develop chondrodysplasia similar to that of DMC/SMC (3 : 0.29 ± 0.022 ml). Deformation-based morphometry (DBM) revealed local volumetric reductions in the frontal cortex, white matter and inferior structures, including the brain stem (Fig. 1C) . Together, these data indicate that Dym −/− mice display a reduction in brain weight and volume and develop microcephaly during the postnatal period.
Dym −/− mice have a smaller frontal cortex and narrowed external capsule and corpus callosum
To determine which parts of the brain are affected in Dym −/− mice, we analyzed coronal sections counterstained with cresyl violet at P30. Five reference planes were chosen for comparisons between Dym −/− and WT brains (anterior (a) to posterior (e)), based on the Franklin and Paxinos mouse brain atlas ( Fig. 2A) . Interestingly, the length of the anteroposterior axis was found to be significantly reduced in Dym −/− brains as compared with WT brains (by 9.73%, Fig. 2B ). The dorsoventral axis was also reduced in the anterior part of the brain (plane a, 4.8%, plane b, 4%). In contrast, no difference in the mediolateral axis was noted between the two groups (not shown). Given that reduced cerebral cortical development is the most common cause of inherited primary microcephaly (16), we next examined the architecture of the cortex, its surface area and its thickness in the five reference planes. The cortical surface area was reduced by 8% in Dym −/− brains, but this reduction was restricted to the most anterior part (Fig. 2C ), consistent with a narrowing of the frontal cortex. The six cortical layers appeared properly organized and cortical thickness did not differ from controls (not shown), except in the most anterior part (Fig. 3A) . This reduction of the frontal cortical thickness was not due to a decreased cell density (Fig. 3C ) but to a significant shortening of the deeper layers (V-VI) (Fig. 3B ). In addition, the area comprising the corpus callosum and the external capsule was reduced in all planes, suggesting possible defects in the white matter (Fig. 2D ).
Myelin is abnormal in Dym −/− brains
In keeping with the results above, we next examined the expression of MBP, one of the most abundant components of the myelin membrane in the central nervous system (CNS) and therefore a good marker for white matter. Immunohistochemical labeling of P30 sections with an anti-MBP antibody confirmed the reduction in the surface area of the corpus callosum in Dym −/− brains ( Fig. 3D and E) , and densitometry further revealed a reduction in MBP expression (Fig. 3E) . Reduced protein levels were confirmed by western blotting of whole brain extracts (Fig. 3F) . Electron microscopic analyses of the white matter revealed thin, poorly compacted and incorrectly rolled myelin sheaths in Dym −/− mutants (Fig. 4A) . In contrast, the number of axons and their diameters were similar in both groups (Fig. 4B) . Measurement of the G-ratio (axon diameter/total fiber diameter) confirmed the strong reduction of the myelin sheath thickness (Fig. 4B) . Moreover, the density of oligodendrocytes (the myelin-forming cells in the CNS), labeled with an antibody to Olig2 (expressed at all stages of oligodendrocytic maturation), was significantly decreased in the corpus callosum of Dym −/− animals at P30 as compared with their WT littermates ( Fig. 4C and D upper panels). A similar decrease in oligodendrocytic density was measured in sections labeled with APC, a marker specific for mature oligodendrocytes ( Fig. 4C and D lower panels). While no cell death was detected in adults, at P5, cleavedcaspase 3 labeling revealed an increased amount of apoptotic nuclei in the corpus callosum of Dym −/− animals ( Fig. 5D ). TUNEL and Olig2 co-labeling confirmed that these dying cells were oligodendrocytes ( Fig. 5C and D) . Together, these data indicate that white matter volume is reduced in Dym −/− brains due to a decrease in the number of oligodendrocytes and axonal hypomyelination.
The Golgi apparatus is markedly enlarged in Dym −/− neurons and oligodendrocytes
As also observed by Denais and colleagues (14) , the Golgi apparatus was markedly disorganized in primary fibroblasts from DMC patients (Supplementary Material, Fig. S1A ). In an effort to understand the link between the defective white matter and cortical development on the one hand and Dymeclin function on the other, we examined the structure and function of the Golgi apparatus in primary neurons and oligodendrocytes from Dym −/− mice.
In primary cortical neuronal cultures from the telencephalon from E14.5 mouse embryos, co-labeling for GM130, a marker of the cisGolgi apparatus, and NeuN, a neuronal marker, revealed a marked enlargement of Golgi stacks in Dym −/− cells ( Fig. 5A and B). In oligodendrocytes from glial-enriched primary cultures prepared from mouse forebrains dissected at P0, the co-labeling of mature oligodendrocytes with GM130 and APC also revealed an abnormally large Golgi apparatus in Dym −/− cultures ( Fig. 5A and B). Confirming these results, the Golgi apparatus of mature neurons and oligodendrocytes was markedly enlarged in cultures differentiated from Dym Anterograde trafficking is impaired in Dym −/− neurons and in human DMC fibroblasts An extensive ER with dilated cisternae has been reported as a hallmark of Dym deficiency in fibroblasts and chondrocytes from both DMC patients (4, 17, 18) and Dym −/− mice (3). Because the Golgi apparatus is affected in Dym-deficient neurons, we asked whether Dymeclin could be involved in anterograde, i.e. ER-to-Golgi, trafficking. To examine trafficking between these two compartments in cortical neurons, we analyzed the retention and release of a Golgi enzyme, mannosidase II (ManII) using the retention using selective hooks (RUSH) system (19) . In this system, the ManII-SBP-GFP fusion protein is initially sequestered in the ER by the KDEL hook until Biotin is added to the culture medium. At steady state, ManII-SBP-GFP was found in the ER as expected in both WT and Dym −/− neurons (Fig. 6 ). One hour after the addition of biotin, which releases SBP from its local hook protein and triggers ManII translocation, we detected ManII-SBP-GFP in the Golgi apparatus in half of the transfected neurons from WT cultures. Two hours after biotin addition, ManII-SBP-GFP was fully translocated to the Golgi apparatus of almost all WT neurons. In contrast, ManII-SBP-GFP was still detected in the ER compartment in the majority of Dym −/− neurons even 2 h after biotin addition (Fig. 6 ). These data show that ER-to-Golgi anterograde trafficking is impaired in Dym-deficient neurons. To check whether this phenomenon could also occur in human DMC cells, we used the same RUSH assay in primary fibroblasts from two patients with previously characterized DYM mutations (2,4). Comparable results were obtained with these DMC fibroblasts, although 40-50% of the transfected cells finally displayed the localization of the reporter in the Golgi apparatus after 2 h of biotin treatment (Fig. 7) . To confirm that the delay in anterograde trafficking was due to the deficiency of Dymeclin, we repeated the RUSH assay in mouse neurons or human fibroblasts overexpressing WT Dym-GFP, using a red fluorescent version (mCherry) of the ManII reporter. Two hours after the addition of biotin, ManII-SBP-mCherry was consistently detected in the Golgi apparatus of both Dym 
Corpus callosum thickness is reduced in DMC patients
Despite the observation of microcephaly and intellectual deficits associated with DMC, white matter defects have not so far been white matter area (highlighted in yellow) composed of the corpus callosum and the external capsule. Ten to fourteen animals per group were used. Results were compared using the Mann-Whitney U-test. A two-tailed P < 0.05 was considered significant. Note that white matter area from Dym −/− mice was reduced in all planes. documented in DMC patients, most likely because of the rarity of the syndrome and the scarcity of cerebral data available. Given our demonstration of the involvement of Dymeclin in neuronal and oligodendrocytic Golgi function in mice, we next examined the thickness of the corpus callosum in cerebral MRIs of two other unrelated DMC patients with well-characterized DYM mutations. Strikingly, these patients not only exhibited microcephaly with a postnatal onset, the thickness of their corpus callosum was markedly reduced (Fig. 8) , consistent with our findings in the brain of Dym −/− mice as well as the observation that Dymeclin deficiency impairs Golgi function, and possibly as a consequence, proper myelination. These findings provide additional support to a role for Dymeclin-mediated intracellular transport in normal brain development.
Discussion
Postnatal microcephaly is a hallmark of DMC syndrome, which is caused by loss-of-function mutations in the human DYM gene (1). Our results show that Dym-deficient mice are a suitable model to study the cerebral phenotype observed in DMC patients -positive nuclei countings (upper graphs). Cell death is significantly higher in Dym −/− animals than in WT. Results were compared using the Mann-Whitney U-test (**P < 0.01, ***P < 0.001). Note the reduced number of oligodendrocytes able to express MBP and the significant reduction of MBP-positive area in primary cultured oligodendrocytes from Dym −/− mice when compared with WT mice (lower graphs). Approximately 150 cells were analyzed, using ImageJ 1.410 software (NIH). Results were compared using the Mann-Whitney U-test (***P < 0.001).
and confirm clinical observations that DYMECLIN deficiency in the human brain induces postnatal-onset microcephaly. In agreement with the progressive appearance of microcephaly that continues during childhood, we observed a marked reduction in the thickness of the corpus callosum in Dym −/− mice, in association with myelination defects, a largely postnatal process (20, 21) . Interestingly, our study also reveals a marked thinning of the corpus callosum in two unrelated DMC patients, confirming our findings in mutant mice and suggesting that white matter defects are central to the pathophysiology of DMC syndrome. As the principal commissure interconnecting the two cerebral hemispheres, the corpus callosum contains more than 200 million axons, and volumetric alterations to this structure likely reflect more general white matter volume defects. Consistent with this hypothesis, the brain stem volume was also found to be reduced in Dym −/− mice, and the medulla oblongata appeared distinctly narrower than normal in the brain MRI of Patient 2. Our data suggest that volumetric MRI to quantify white matter volume and density should be systematically performed in children with DMC to better characterize these newly identified structural anomalies, which might represent an important feature of the DMC brain phenotype. These findings also provide a relevant explanation for the low IQ and specific language difficulties frequently described in DMC patients, especially as previous studies have evidenced a substantial correlation between general intelligence and white matter volume (22, 23) . What is the mechanism underlying this postnatal development of white matter defects and microcephaly? Our data show that Dymeclin deficiency results in thinner, less compact and improperly rolled myelin membranes. In the CNS, myelination is carried out by oligodendrocytes, which enwrap axons to form the myelin sheath (24) . Given that fewer oligodendrocytes were found in Dym −/− brains and that the remaining mature oligodendrocytes displayed an abnormal Golgi structure along with a decreased ability to produce MBP, it is likely that Dymeclin is required for full oligodendrocyte maturation. Oligodendrocytes send out plasma membrane extensions that become more and more branched as the cell differentiates, allowing a single mature oligodendrocyte to ensheathe several axons. Although MBP proteins are synthesized locally in these plasma membrane extensions following the specific transport of MBP mRNAs (25) , the sorting and transport of other myelin components and lipids requires intensive trafficking, in which the Golgi apparatus actively participates and which could be impaired by Dymeclin deficiency (26) . In line with these observations, the Golgi apparatus also displayed abnormal morphology in Dym-deficient mouse neurons. is sequestered in the ER (co-localized with the ER marker Calnexin (Calx, red)) by the KDEL hook in both WT and Dym −/− neurons. Upon biotin addition, ManII-SBP-GFP is released into the Golgi apparatus (co-localized with the Golgi marker GM130 ( pink)) where it is found in all transfected neurons from WT cultures after 120 min. In neurons from Dym −/− cultures, the Golgi translocation of ManII-SBP-GFP is strongly delayed. For each condition, an average of 40 neurons was counted and neurons were assigned to three groups depending on whether ManII-SBP-GFP was found in the ER, the Golgi apparatus (Golgi) or in both compartments (ER Golgi). Neurons are stained with the neuronal marker MAP2 (red). Results were compared using a two-way ANOVA followed by a post-hoc Bonferroni multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.001).
Although we did not detect abnormal neuronal cell death at P5 and P30, the possibility that neuronal numbers are also modified, although to a lesser extent than the number of oligodendrocytes or at later stages cannot be ruled out. In addition to the abnormal morphology of the Golgi stacks, we observed slowed ER-to-Golgi trafficking in both primary neurons and DMC fibroblasts that could be completely rescued upon Dym-GFP expression. This observation is in agreement with previous findings showing the delayed relocation of GM130 to the Golgi in Dym −/ − mouse fibroblasts recovering from Brefeldin-A treatment, which causes the reversible redistribution of Golgi membranes to the ER (3). Moreover, DMC patient fibroblasts expressing naturally secreted Gaussia luciferase (Gluc), used to assess the efficiency of the secretory pathway (27) , displayed reduced secretion capacities, again implicating Dymeclin in anterograde trafficking (data not shown). These results potentially uncover a novel link between the localization of Dymeclin in the Golgi apparatus, and the appearance of structural brain defects including microcephaly. In recent years, several Golgi-resident proteins have been implicated in genetic disorders that involve postnatal-onset microcephaly, including RAB18, RAB1GAP and RAB2GAP in Warburg Micro syndrome (28, 29) , VPS53 in progressive cerebello-cerebral atrophy type 2 (30) and TRAPPC9 in some idiopathic intellectual disability (31) (32) (33) . Very interestingly, all these proteins are directly involved in the activation/inactivation cycle of the RabGTPases (34) and play a role in the regulation of Golgi vesicle trafficking. Moreover, their loss-of-function has been directly associated with clinical features that include corpus callosum hypoplasia. Hence, our study, in conjunction with the probable link between Dymeclin and RAB33 (12,13), (i) indicates that Dymeclin is involved in the regulation of Golgi vesicle trafficking in several cell types, including oligodendrocytes and neurons and (ii) reinforces the hypothesis that the secretory functions of the Golgi apparatus play a central role in the proper development and maturation of both the white matter and cortex in humans and mice.
In conclusion, our data indicate that Dymeclin deficiency results in postnatal microcephaly through a mechanism involving defective myelination and impaired Golgi trafficking in neural cells. Further work is needed to explore the consequences of defective ER-to-Golgi anterograde transport on myelination and axonal transport, and to understand the precise role of Dymeclin in this process, and more widely the role of the secretory traffic in microcephaly.
Materials and Methods
Immunohistochemistry and immunocytochemistry
Mice were sacrificed and the whole brain was dissected out from the level of the foramen magnum to the most rostral part including olfactory bulbs, immediately weighed, fixed in formalin and embedded in paraffin. Coronal sections 16 μm-thick were mounted on gelatin-coated slides, stained with cresyl violet or immunolabeled with anti-MBP (1:100, MAB382, Millipore), antiOlig2 . Functional analysis of ER-to-Golgi trafficking using the RUSH system in primary fibroblasts from a control and two DMC patients. Retention and release analysis of the Golgi enzyme ManII-SBP-GFP in the absence (non-treated) or presence of biotin (60 and 120 min incubation). In non-treated cultures, ManII-SBP-GFP is sequestered in the ER by the KDEL hook as expected in both WT and DMC fibroblasts. Upon biotin addition, ManII-SBP-GFP is released into the Golgi apparatus where it is found in all transfected cells from WT cultures after 120 min. In contrast, in fibroblasts from DMC cultures, the Golgi translocation of ManII-SBP-GFP is strongly delayed. Primary fibroblasts were transfected at passages P8-10. Fibroblasts from DMC Patients 1 and 2 carry distinct homozygous mutations in DYM (g.IVS3-1G > A and c.1877delA, respectively). Cells were assigned to three groups depending on whether ManII-SBP-GFP was found in the ER, the Golgi apparatus (Golgi) or in both compartments (ER Golgi). For each condition, an average of 100 transfected fibroblasts was counted. Results were compared using a two-way ANOVA followed by a post-hoc Bonferroni multiple comparison test (**P < 0.01, ***P < 0.001). 
Histomorphometric analyses
Brains coronal sections from P30 mice were stained with cresyl violet and imaged using a Zeiss SteREO Discovery V12 microscope. Five anteroposterior levels (a-e) were selected based on relevant anatomical landmarks of WT mice (36) . For each level, we measured (i) the dorsoventral and mediolateral axes, (ii) the surface area of the entire cortex, (iii) the surface area of the white matter comprising the corpus callosum and/or the external capsule, the boundary of the two structures being defined by the position of the cingulum and (iv) the thickness of the motor and somatosensory cortex. The length of the anteroposterior axis was deduced from the number of sections generated between a and e. Measurements were done using Image-J software and quantitative data expressed as means ± SEM.
Human and mouse MRI analyses
Human cerebral MRI was performed as described (37) . For mouse MRI, brains (WT = 5, Dym −/− = 5) were imaged on a 9.4 T Varian scanner, using a 3D spoiled gradient echo sequence with a 100G/cm gradient-coil and 33-mm Rapid RF quadrature volume-coil; TR 150 ms, TE 4.6 ms and flip angle 35°. For DBM, a single control mouse was chosen for reference images. All other images were aligned to this reference using affine followed by non-linear registration implemented with the IRTK package (38, 39) . A reference image was created by taking the intensity average of the aligned images, and three further iterations of registration were performed, using an updated intensity average as the reference image. A measure of local volume change induced by the transformation between each image and the final reference image was obtained from the determinant of the Jacobian operator applied to the transformation. A voxelwise statistical comparison of volume relative to the reference image, represented by the Jacobian determinant, was performed with Randomise, implemented in FSL, v4.1 (40) .
Primary cultures and transfection
Primary cortical neurons were extracted from the forebrain of E14.5 embryos using 0.25% trypsin dissociation (Invitrogen), 0.6 mg/ml DNase I digestion (Sigma) and manual dissociation in Minimum Essential Medium (Sigma) supplemented with 10% horse serum, antibiotics, 2 m glutamine (Invitrogen), 7.5% sodium bicarbonate (Invitrogen) and 0.6% glucose (Sigma). Cells were maintained in Neurobasal medium (Invitrogen) supplemented with B21 (Miltenyi Biotec) and 5 m glutamine at 37°C in a humidified 5% CO 2 incubator. Primary oligodendrocytes were prepared from neonatal mouse brains and cells were maintained at 37°C in a humidified 5% CO 2 incubator for 7 days in proliferation medium (MEM (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen), 1% glutamax and 0.5% glucose) and for 10 additional days in differentiation medium (DMEM-F12 (Invitrogen) supplemented with 1% N2 (Invitrogen), 40 ng/ml T3 (Sigma)). Media were changed every alternate day. Neuronal transfection was adapted from (41): at DIV5, half the medium (hM) was removed and kept at 37°C while neurons were exposed to a calcium-phosphate/DNA complex for 60 min. Fresh medium pre-warmed in a 10% CO 2 atmosphere for 4 h was added to the culture to reduce calcium-phosphate-complex toxicity. Neurons were rinsed with fresh medium and hM replaced. Human dermal fibroblasts from DMC patients and unaffected age-matched individuals were derived from skin biopsies and grown in MEM (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen), 1% glutamax, antibiotics and 0.5% glucose. For transfection, fibroblasts were electroporated using the Neon transfection system (Invitrogen) and plated on coverslips for 24 h.
Electron microscopy
Mice were perfused transaortically with 20 ml saline followed by 100 ml of 2% paraformaldehyde with 2% glutaraldehyde at 4°C. Brains were post-fixed in 2% paraformaldehyde at 4°C. Sagittal sections 70 μm-thick were post-fixed in 1% glutaraldehyde for 10 min, treated with 1% osmium tetroxide for 10 min and dehydrated in an ascending series of ethanol solutions. Sections were treated with propylene oxide, equilibrated in Durcupan ACM (Fluka), flat-embedded on glass slides and cured at 60°C for 48 h. Blocks of the trunk of the corpus callosum close to the midline were cut out from the sections and glued to blank cylinders of resin. Ultrathin sections were cut on a Reichert Ultracut S microtome, collected on pioloform-coated single-slot grids, stained with lead citrate and analyzed using a Philips CM120 electron microscope equipped with Morada Imaging System (Olympus).
Western blot analysis
Brains were dissected out from P30 mice (WT = 10, Dym −/− = 10), crushed in lysis buffer supplemented with protease inhibitors and centrifuged. Lysates were heat-denatured, separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes. Membranes were probed with anti-MBP (1:2000, MAB382, Millipore) or antiactin antibodies (1:10 000, MAB1501, Millipore). Signal was detected by chemiluminescence and quantified using Image-J.
Analysis of trafficking kinetics of the ManII-SBP-EGFP cargo
Trafficking kinetics between the ER and the Golgi were evaluated using the RUSH system (19) . Mouse primary cortical neurons or human fibroblasts transiently expressing KDEL-streptavidin as a hook and the Golgi enzyme ManII-SBP-EGFP (or -mCherry) as a reporter were imaged either before or 60 and 120 min after biotin addition (40 µ). Ten fields were counted (40-100 transfected cells per condition) and each fluorescent cell classified according to the location of the reporter in the ER, ER/Golgi or Golgi. Experiments were repeated three times, independently.
Animals and ethics statement
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